Could a One-Month TB pill be as good as three? new trial tests shorter prevention
NCT ID NCT05118490
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether taking two TB prevention drugs daily for one month works as well as taking them weekly for three months. It includes 1,000 people with HIV or those living with someone recently diagnosed with TB. The goal is to see which schedule more people complete and how safe and cost-effective each option is.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV SEROPOSITIVITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fundação Aurum (The Aurum Institute Mozambique)
Chokwé, Gaza Province, Mozambique
-
The Aurum Institute: Gavin J Churchyard Legacy Centre
Klerksdorp, North West, 2571, South Africa
-
The Byramjee Jeejeebhoy Medical Centre (BJGMC-JHU) CRS
Pune, Maharashtra, 411001, India
-
Yayasan KNCV - The Persahabatan Hospital, Jakarta
Jakarta, Jaya, 14350, Indonesia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can immune profiling unlock the hidden stages of tuberculosis?
- Could inhaled TB drugs curb the spread of Drug-Resistant tuberculosis?
- Can new tests predict who will develop active TB?
- Could a 3-Month TB cocktail replace the standard 6-Month regimen?
- Could a simple blood test ensure the right TB dose for kids?
- Community-Driven TB screening aims to reach vulnerable immigrants